TRISEQUENS N cpr pell 28 pce

7680400510243 CH-40051 G03FB05 07.08.6.
TRISEQUENS N cpr pell 28 pce
TRISEQUENS N cpr pell 28 pce
TRISEQUENS N cpr pell 28 pce
1 / 3
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
4005105
CPT
-
Packaging group
28
Unit
Tablette(n)
Composition
A) Filmtablette blau: estradiolum 2 mg ut estradiolum hemihydricum 2.07 mg, lactosum monohydricum 36.8 mg, maydis amylum, hydroxypropylcellulosum, talcum, magnesii stearas, Überzug: macrogolum 400, hypromellosum, talcum, E 132, E 171, pro compresso obducto. B) Filmtablette weiss: estradiolum 2 mg ut estradiolum hemihydricum, norethisteroni acetas 1 mg, lactosum monohydricum 36.3 mg, maydis amylum, hydroxypropylcellulosum, talcum, magnesii stearas, Überzug: hypromellosum, triacetinum, talcum, pro compresso obducto. C) Filmtablette rot: estradiolum 1 mg ut estradiolum hemihydricum, lactosum monohydricum 37.3 mg, maydis amylum, hydroxypropylcellulosum, talcum, magnesii stearas, Überzug: propylenglycolum, talcum, hypromellosum, E 171, E 172 (rubrum), pro compresso obducto.

Articles (1)

Trisequens N, Filmtabletten
Filmtabletten
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
11/06/2025
Patient information leaflet
Français
11/06/2025
Patient information leaflet
Italien
11/06/2025
Professional SmPC
Allemand
11/06/2025
Professional SmPC
Français
11/06/2025
Professional SmPC
Italien
11/06/2025

Detailed composition

Substance Quantity Type Category
estradiolum
2.0 MG Substance Wirkstoff (Principe actif)
estradiolum
2.0 MG Substance Wirkstoff (Principe actif)
estradiolum
1.0 MG Substance Wirkstoff (Principe actif)
estradiolum hemihydricum
2.07 MG Substance WIZUS
estradiolum hemihydricum
- Substance WIZUS
estradiolum hemihydricum
- Substance WIZUS
lactosum monohydricum
37.3 MG Substance HBESI
norethisteroni acetas
1.0 MG Substance Wirkstoff (Principe actif)
lactosum monohydricum
36.8 MG Substance HBESI
maydis amylum
- Substance HNIDK
maydis amylum
- Substance HNIDK
lactosum monohydricum
36.3 MG Substance HBESI
hydroxypropylcellulosum
- Substance HNIDK
maydis amylum
- Substance HNIDK
hydroxypropylcellulosum
- Substance HNIDK
hydroxypropylcellulosum
- Substance HNIDK
talcum
- Substance HNIDK
talcum
- Substance HNIDK
talcum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
magnesii stearas
- Substance HNIDK
magnesii stearas
- Substance HNIDK
macrogolum 400
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
propylenglycolum
- Substance HNIDK
hypromellosum
- Substance HNIDK
hypromellosum
- Substance HNIDK
talcum
- Substance HNIDK
hypromellosum
- Substance HNIDK
talcum
- Substance HNIDK
triacetinum
- Substance HNIDK
E 132
- Substance FIMDK
talcum
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (rubrum)
- Substance FTODK
E 171
- Substance FNIDK

Reimbursement information

Public price
CHF 15.10
Specialties list
Yes
Generic
No
SL addition date: 15/03/1978

Authorization holder

Novo Nordisk Pharma AG

8302 Kloten

Authorization information

Swissmedic authorization number
40051
Drug name
Trisequens N, Filmtabletten
Galenic form
FILM
ATC Code
G03FB05
Authorization status
Z
Dispensation category
B
First authorization
17/05/1977
Authorization expiration date
28/02/2027
IT number
07.08.6.
Domain
Human medicine
Field of application
Oestrogen-Gestagen-Substitutionstherapie bei klimakterischen Beschwerden

Packaging details

Description (FR)
TRISEQUENS N cpr pell 28 pce
Description (DE)
TRISEQUENS N Filmtabl 28 Stk
Market launch
21/06/2011
Narcotic (BTM)
No

Other packaging sizes

Buy us a coffee Explore the data